Medication AbortionNCT07405294
TeleMAb Retrospective Cohort Study
An observational study of Medication Abortion and Telemedicine, run by Columbia University at 1 site in United States.
Trial summary
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care… Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Medication Abortion, Telemedicine
- What is being tested?
- Telemedicine Medication Abortion
- How many people
- 400 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Jun 2023to 31 Jul 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Study population: Biologically female patients of reproductive age with an unwanted pregnancy seeking care at Columbia University's family planning clinics and interested in medication abortion.
Who may be able to join
- Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
- Gestational age <70 days (based on best obstetrical dating)
- English or Spanish speaking
Who cannot join
- Received mifepristone and misoprostol for early pregnancy loss
- Patient determined to have contraindication to medication abortion
- Opted for procedural management instead of medication abortion
- Decided to continue with the pregnancy
- Presenting for a second medication abortion at CUIMC during the study period
- Non-English or Spanish speaking
Trial locations and contacts
1 site in 1 country.
United States1 site
Columbia University Irving Medical Center
New York, New York, 10032-3720
About this study
Official title: A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
Read the detailed description
This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.
- Conditions
- Medication Abortion, Telemedicine
- Being tested
- Telemedicine Medication Abortion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemedicine Medication AbortionOther
Meeting with a clinician via video visit to determine if patient is eligible for medication abortion without pre-treatment ultrasound or laboratory testing. If eligible, the patient travels to clinic to pick up medications in person.
| Study group | Role | What they receive |
|---|---|---|
| Telemedicine Med Ab | Patients who received medication abortion through the telemedicine medication abortion service during the study period. Receives: Other: Telemedicine Medication Abortion | |
| In-person Med Ab | Patients who received an in-person medication abortion at the clinic during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of unscheduled follow-ups
If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion
Measured: 3 months after initial encounter
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2026
- Study start12 Jun 2023
- Primary completion15 Nov 2025
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication AbortionStudies of the same condition, open and under way.
- More trials run by Columbia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Erika Levi, MD, Columbia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07405294
- Sponsor's protocol ID
- AAAV5073
- Status last verified
- Feb 2026
- First submitted
- 4 Feb 2026
- Last updated
- 12 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion
- ClinicalTrials.gov ID
- NCT07405294
- Acronym / sponsor ID
- AAAV5073
- Conditions
- Medication Abortion, Telemedicine
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Columbia UniversityUniversity, hospital or other
- Study start
- 12 Jun 2023 (actual)
- Primary completion
- 15 Nov 2025 (actual)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 12 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
Detailed description
This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Telemedicine Med Ab | – | Other: Telemedicine Medication AbortionPatients who received medication abortion through the telemedicine medication abortion service during the study period. |
| In-person Med Ab | – | –Patients who received an in-person medication abortion at the clinic during the study period. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Biologically female patients of reproductive age with an unwanted pregnancy seeking care at Columbia University's family planning clinics and interested in medication abortion.
Key inclusion criteria (3 listed)
- Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
- Gestational age <70 days (based on best obstetrical dating)
- English or Spanish speaking
Key exclusion criteria (6 listed)
- Received mifepristone and misoprostol for early pregnancy loss
- Patient determined to have contraindication to medication abortion
- Opted for procedural management instead of medication abortion
- Decided to continue with the pregnancy
- Presenting for a second medication abortion at CUIMC during the study period
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telemedicine Medication AbortionMeeting with a clinician via video visit to determine if patient is eligible for medication abortion without pre-treatment ultrasound or laboratory testing. If eligible, the patient travels to clinic to pick up medications in person. | Other | Telemedicine Med Ab |
Primary outcome
Number of unscheduled follow-ups
Time frame: 3 months after initial encounter
If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medication Abortion and Telemedicine, run by Columbia University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of unscheduled follow-ups (time frame: 3 months after initial encounter). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026; AzTrials last refreshed its copy on 27 Oct 2026.